达托霉素、万古霉素、替考拉宁和利奈唑胺对来自印度西部两个大型中心的耐革兰氏阳性菌分离株的体外活性比较 - Suppr | 超能文献

Comparative in vitro activities of daptomycin, vancomycin, teicoplanin and linezolid against resistant Gram-positive bacterial isolates from two large centres in western India.

作者信息

Biswas Sanjay, Watwani Jaya, Vadwai Viral, Shetty Anjali, Kelkar Rohini, Rodrigues Camilla

出版信息

Int J Antimicrob Agents. 2012 Dec;40(6):567-9. doi: 10.1016/j.ijantimicag.2012.07.013. Epub 2012 Sep 1.

DOI:10.1016/j.ijantimicag.2012.07.013

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comparative in vitro activities of daptomycin, vancomycin, teicoplanin and linezolid against resistant Gram-positive bacterial isolates from two large centres in western India.达托霉素、万古霉素、替考拉宁和利奈唑胺对来自印度西部两个大型中心的耐革兰氏阳性菌分离株的体外活性比较

Int J Antimicrob Agents. 2012 Dec;40(6):567-9. doi: 10.1016/j.ijantimicag.2012.07.013. Epub 2012 Sep 1.

2

Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.达托霉素、利奈唑胺和奎奴普丁/达福普汀对某大型癌症中心革兰氏阳性菌分离株的体外活性比较

Diagn Microbiol Infect Dis. 2005 Jul;52(3):255-9. doi: 10.1016/j.diagmicrobio.2005.02.015.

3

[Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].达托霉素对革兰氏阳性微生物的体外比较活性：西班牙哨兵监测项目（2002 - 2006年）

Enferm Infecc Microbiol Clin. 2008 Oct;26(8):489-94.

4

Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).达托霉素对印度医疗中心革兰氏阳性菌分离株的活性（2006 - 2007年）

Int J Antimicrob Agents. 2009 Nov;34(5):497-9. doi: 10.1016/j.ijantimicag.2009.06.008. Epub 2009 Jul 19.

5

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.达巴万星及其他12种药物对从糖尿病足感染中分离出的329株需氧和厌氧革兰氏阳性菌的体外活性。

Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9. doi: 10.1128/AAC.00286-06.

6

In vitro study to evaluate the sensitivity to daptomycin among gram positive clinical isolates.

Indian J Med Microbiol. 2012 Jan-Mar;30(1):114-5. doi: 10.4103/0255-0857.93088.

7

Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).中国 5608 株临床革兰阳性菌的耐药趋势：革兰阳性球菌耐药监测项目（2005-2010 年）结果。

Diagn Microbiol Infect Dis. 2012 Jun;73(2):174-81. doi: 10.1016/j.diagmicrobio.2012.03.003. Epub 2012 Apr 21.

8

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.台湾地区达托霉素、糖肽类、利奈唑胺和替加环素对革兰氏阳性菌血液分离株的杀菌活性比较

Clin Microbiol Infect. 2008 Feb;14(2):124-9. doi: 10.1111/j.1469-0691.2007.01888.x. Epub 2007 Dec 10.

9

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估：哨兵计划报告（2003 - 2004年）

Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.

10

Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study.来自欧洲和中东地区的革兰氏阳性和革兰氏阴性分离株的头孢托罗比对活性：CLASS 研究。

J Antimicrob Chemother. 2011 Jan;66(1):151-9. doi: 10.1093/jac/dkq397.

引用本文的文献

1

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.全球达托霉素、替加环素、奎奴普丁/达福普汀和利奈唑胺耐药金黄色葡萄球菌和凝固酶阴性葡萄球菌菌株的流行情况：系统评价和荟萃分析。

Antimicrob Resist Infect Control. 2020 Apr 22;9(1):56. doi: 10.1186/s13756-020-00714-9.

2

Daptomycin resistance in methicillin-resistant Staphylococcus aureus: a report from Southern India.耐甲氧西林金黄色葡萄球菌中达托霉素耐药性：来自印度南部的报告。

Germs. 2014 Sep 1;4(3):70-2. doi: 10.11599/germs.2014.1058. eCollection 2014 Sep.